nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Dexamethasone—psoriatic arthritis	0.141	0.212	CbGbCtD
Fingolimod—CYP3A4—Methylprednisolone—psoriatic arthritis	0.113	0.17	CbGbCtD
Fingolimod—CYP3A4—Triamcinolone—psoriatic arthritis	0.0853	0.129	CbGbCtD
Fingolimod—CYP3A4—Betamethasone—psoriatic arthritis	0.0732	0.111	CbGbCtD
Fingolimod—CYP3A4—Prednisolone—psoriatic arthritis	0.0722	0.109	CbGbCtD
Fingolimod—CYP3A4—Prednisone—psoriatic arthritis	0.0682	0.103	CbGbCtD
Fingolimod—CYP2D6—Dexamethasone—psoriatic arthritis	0.067	0.101	CbGbCtD
Fingolimod—CYP3A4—Dexamethasone—psoriatic arthritis	0.0426	0.0644	CbGbCtD
Fingolimod—X-linked lymphoproliferative syndrome—Methotrexate—psoriatic arthritis	0.0174	0.0596	CcSEcCtD
Fingolimod—Lymphoproliferative disorder—Methotrexate—psoriatic arthritis	0.0174	0.0596	CcSEcCtD
Fingolimod—Hepatic enzyme increased—Auranofin—psoriatic arthritis	0.0128	0.044	CcSEcCtD
Fingolimod—Depressed mood—Methylprednisolone—psoriatic arthritis	0.00794	0.0273	CcSEcCtD
Fingolimod—Weight decreased—Auranofin—psoriatic arthritis	0.00689	0.0236	CcSEcCtD
Fingolimod—Lymphoma—Methotrexate—psoriatic arthritis	0.00672	0.0231	CcSEcCtD
Fingolimod—Eye disorder—Auranofin—psoriatic arthritis	0.00569	0.0196	CcSEcCtD
Fingolimod—Lymphopenia—Prednisone—psoriatic arthritis	0.00549	0.0189	CcSEcCtD
Fingolimod—Visual acuity reduced—Betamethasone—psoriatic arthritis	0.00543	0.0186	CcSEcCtD
Fingolimod—Visual acuity reduced—Dexamethasone—psoriatic arthritis	0.00543	0.0186	CcSEcCtD
Fingolimod—Alopecia—Auranofin—psoriatic arthritis	0.00538	0.0185	CcSEcCtD
Fingolimod—SPHK1—Betamethasone—Methylprednisolone—psoriatic arthritis	0.00494	0.105	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.00494	0.105	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Betamethasone—psoriatic arthritis	0.00486	0.104	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Dexamethasone—psoriatic arthritis	0.00486	0.104	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Triamcinolone—psoriatic arthritis	0.00475	0.101	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Triamcinolone—psoriatic arthritis	0.00475	0.101	CbGdCrCtD
Fingolimod—Leukopenia—Auranofin—psoriatic arthritis	0.00475	0.0163	CcSEcCtD
Fingolimod—SPHK1—Betamethasone—Prednisone—psoriatic arthritis	0.00451	0.0961	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Prednisone—psoriatic arthritis	0.00451	0.0961	CbGdCrCtD
Fingolimod—SPHK1—Betamethasone—Prednisolone—psoriatic arthritis	0.0044	0.0938	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Prednisolone—psoriatic arthritis	0.0044	0.0938	CbGdCrCtD
Fingolimod—Blood triglycerides increased—Prednisone—psoriatic arthritis	0.00429	0.0147	CcSEcCtD
Fingolimod—Herpes zoster—Methotrexate—psoriatic arthritis	0.00312	0.0107	CcSEcCtD
Fingolimod—Pruritus—Auranofin—psoriatic arthritis	0.00306	0.0105	CcSEcCtD
Fingolimod—Diarrhoea—Auranofin—psoriatic arthritis	0.00296	0.0102	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00267	0.00917	CcSEcCtD
Fingolimod—Eye pain—Dexamethasone—psoriatic arthritis	0.0026	0.00891	CcSEcCtD
Fingolimod—Eye pain—Betamethasone—psoriatic arthritis	0.0026	0.00891	CcSEcCtD
Fingolimod—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.00248	0.00853	CcSEcCtD
Fingolimod—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.00246	0.00843	CcSEcCtD
Fingolimod—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.00245	0.00841	CcSEcCtD
Fingolimod—Migraine—Betamethasone—psoriatic arthritis	0.00231	0.00792	CcSEcCtD
Fingolimod—Migraine—Dexamethasone—psoriatic arthritis	0.00231	0.00792	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.00227	0.0078	CcSEcCtD
Fingolimod—Influenza—Triamcinolone—psoriatic arthritis	0.00223	0.00766	CcSEcCtD
Fingolimod—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00223	0.00765	CcSEcCtD
Fingolimod—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00223	0.00765	CcSEcCtD
Fingolimod—Bronchitis—Triamcinolone—psoriatic arthritis	0.00215	0.00737	CcSEcCtD
Fingolimod—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00199	0.00682	CcSEcCtD
Fingolimod—Infestation—Methylprednisolone—psoriatic arthritis	0.00199	0.00682	CcSEcCtD
Fingolimod—Bradycardia—Prednisolone—psoriatic arthritis	0.00198	0.00679	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisone—psoriatic arthritis	0.00194	0.00666	CcSEcCtD
Fingolimod—Weight decreased—Dexamethasone—psoriatic arthritis	0.00183	0.00629	CcSEcCtD
Fingolimod—Weight decreased—Betamethasone—psoriatic arthritis	0.00183	0.00629	CcSEcCtD
Fingolimod—Bradycardia—Triamcinolone—psoriatic arthritis	0.00182	0.00625	CcSEcCtD
Fingolimod—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00181	0.00623	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.0018	0.00618	CcSEcCtD
Fingolimod—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00175	0.00602	CcSEcCtD
Fingolimod—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.00174	0.00598	CcSEcCtD
Fingolimod—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00167	0.00572	CcSEcCtD
Fingolimod—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00165	0.00568	CcSEcCtD
Fingolimod—Bradycardia—Dexamethasone—psoriatic arthritis	0.00165	0.00567	CcSEcCtD
Fingolimod—Bradycardia—Betamethasone—psoriatic arthritis	0.00165	0.00567	CcSEcCtD
Fingolimod—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00162	0.00555	CcSEcCtD
Fingolimod—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00161	0.00552	CcSEcCtD
Fingolimod—Weight decreased—Prednisone—psoriatic arthritis	0.0016	0.00548	CcSEcCtD
Fingolimod—Vision blurred—Prednisolone—psoriatic arthritis	0.00159	0.00547	CcSEcCtD
Fingolimod—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00157	0.00541	CcSEcCtD
Fingolimod—Depression—Prednisone—psoriatic arthritis	0.00157	0.00538	CcSEcCtD
Fingolimod—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00156	0.00536	CcSEcCtD
Fingolimod—Eye disorder—Betamethasone—psoriatic arthritis	0.00152	0.0052	CcSEcCtD
Fingolimod—Eye disorder—Dexamethasone—psoriatic arthritis	0.00152	0.0052	CcSEcCtD
Fingolimod—Back pain—Triamcinolone—psoriatic arthritis	0.0015	0.00517	CcSEcCtD
Fingolimod—Angiopathy—Dexamethasone—psoriatic arthritis	0.00147	0.00505	CcSEcCtD
Fingolimod—Angiopathy—Betamethasone—psoriatic arthritis	0.00147	0.00505	CcSEcCtD
Fingolimod—Hypertension—Prednisolone—psoriatic arthritis	0.00146	0.00501	CcSEcCtD
Fingolimod—Bradycardia—Prednisone—psoriatic arthritis	0.00144	0.00494	CcSEcCtD
Fingolimod—Alopecia—Betamethasone—psoriatic arthritis	0.00143	0.00492	CcSEcCtD
Fingolimod—Alopecia—Dexamethasone—psoriatic arthritis	0.00143	0.00492	CcSEcCtD
Fingolimod—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00139	0.00476	CcSEcCtD
Fingolimod—Cough—Triamcinolone—psoriatic arthritis	0.00136	0.00466	CcSEcCtD
Fingolimod—Hypertension—Triamcinolone—psoriatic arthritis	0.00134	0.00461	CcSEcCtD
Fingolimod—Hypertension—Methylprednisolone—psoriatic arthritis	0.00134	0.0046	CcSEcCtD
Fingolimod—Pneumonia—Methotrexate—psoriatic arthritis	0.00132	0.00454	CcSEcCtD
Fingolimod—Eye disorder—Prednisone—psoriatic arthritis	0.00132	0.00453	CcSEcCtD
Fingolimod—Infestation NOS—Methotrexate—psoriatic arthritis	0.00131	0.00451	CcSEcCtD
Fingolimod—Infestation—Methotrexate—psoriatic arthritis	0.00131	0.00451	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00131	0.00451	CcSEcCtD
Fingolimod—Depression—Methotrexate—psoriatic arthritis	0.00131	0.0045	CcSEcCtD
Fingolimod—Angiopathy—Prednisone—psoriatic arthritis	0.00128	0.0044	CcSEcCtD
Fingolimod—Infection—Triamcinolone—psoriatic arthritis	0.00126	0.00433	CcSEcCtD
Fingolimod—Infection—Methylprednisolone—psoriatic arthritis	0.00126	0.00432	CcSEcCtD
Fingolimod—Alopecia—Prednisone—psoriatic arthritis	0.00125	0.00428	CcSEcCtD
Fingolimod—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00124	0.00426	CcSEcCtD
Fingolimod—Paraesthesia—Prednisolone—psoriatic arthritis	0.00124	0.00426	CcSEcCtD
Fingolimod—Mental disorder—Prednisone—psoriatic arthritis	0.00124	0.00425	CcSEcCtD
Fingolimod—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00123	0.00422	CcSEcCtD
Fingolimod—Hypertension—Betamethasone—psoriatic arthritis	0.00122	0.00418	CcSEcCtD
Fingolimod—Hypertension—Dexamethasone—psoriatic arthritis	0.00122	0.00418	CcSEcCtD
Fingolimod—Hypotension—Methylprednisolone—psoriatic arthritis	0.00118	0.00406	CcSEcCtD
Fingolimod—Vision blurred—Prednisone—psoriatic arthritis	0.00116	0.00398	CcSEcCtD
Fingolimod—Infection—Dexamethasone—psoriatic arthritis	0.00114	0.00393	CcSEcCtD
Fingolimod—Infection—Betamethasone—psoriatic arthritis	0.00114	0.00393	CcSEcCtD
Fingolimod—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00114	0.00391	CcSEcCtD
Fingolimod—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00114	0.00391	CcSEcCtD
Fingolimod—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00113	0.00389	CcSEcCtD
Fingolimod—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00113	0.00388	CcSEcCtD
Fingolimod—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00113	0.00388	CcSEcCtD
Fingolimod—Eye disorder—Methotrexate—psoriatic arthritis	0.0011	0.00379	CcSEcCtD
Fingolimod—Cardiac disorder—Methotrexate—psoriatic arthritis	0.0011	0.00376	CcSEcCtD
Fingolimod—Fatigue—Triamcinolone—psoriatic arthritis	0.00109	0.00376	CcSEcCtD
Fingolimod—Fatigue—Methylprednisolone—psoriatic arthritis	0.00109	0.00375	CcSEcCtD
Fingolimod—Hypotension—Dexamethasone—psoriatic arthritis	0.00108	0.0037	CcSEcCtD
Fingolimod—Hypotension—Betamethasone—psoriatic arthritis	0.00108	0.0037	CcSEcCtD
Fingolimod—Angiopathy—Methotrexate—psoriatic arthritis	0.00107	0.00368	CcSEcCtD
Fingolimod—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00106	0.00365	CcSEcCtD
Fingolimod—Hypertension—Prednisone—psoriatic arthritis	0.00106	0.00364	CcSEcCtD
Fingolimod—Alopecia—Methotrexate—psoriatic arthritis	0.00104	0.00358	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00104	0.00357	CcSEcCtD
Fingolimod—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00103	0.00355	CcSEcCtD
Fingolimod—Paraesthesia—Betamethasone—psoriatic arthritis	0.00103	0.00355	CcSEcCtD
Fingolimod—Mental disorder—Methotrexate—psoriatic arthritis	0.00103	0.00355	CcSEcCtD
Fingolimod—Infection—Prednisone—psoriatic arthritis	0.000996	0.00342	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000994	0.00341	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000994	0.00341	CcSEcCtD
Fingolimod—Back pain—Methotrexate—psoriatic arthritis	0.000994	0.00341	CcSEcCtD
Fingolimod—Fatigue—Dexamethasone—psoriatic arthritis	0.000993	0.00341	CcSEcCtD
Fingolimod—Fatigue—Betamethasone—psoriatic arthritis	0.000993	0.00341	CcSEcCtD
Fingolimod—Nervous system disorder—Prednisone—psoriatic arthritis	0.000984	0.00338	CcSEcCtD
Fingolimod—Skin disorder—Prednisone—psoriatic arthritis	0.000974	0.00335	CcSEcCtD
Fingolimod—Vision blurred—Methotrexate—psoriatic arthritis	0.000968	0.00332	CcSEcCtD
Fingolimod—Leukopenia—Methotrexate—psoriatic arthritis	0.000919	0.00316	CcSEcCtD
Fingolimod—Dizziness—Prednisolone—psoriatic arthritis	0.000913	0.00313	CcSEcCtD
Fingolimod—Asthenia—Triamcinolone—psoriatic arthritis	0.000911	0.00313	CcSEcCtD
Fingolimod—Asthenia—Methylprednisolone—psoriatic arthritis	0.000909	0.00312	CcSEcCtD
Fingolimod—Paraesthesia—Prednisone—psoriatic arthritis	0.000901	0.00309	CcSEcCtD
Fingolimod—Pruritus—Triamcinolone—psoriatic arthritis	0.000898	0.00308	CcSEcCtD
Fingolimod—Cough—Methotrexate—psoriatic arthritis	0.000896	0.00308	CcSEcCtD
Fingolimod—Pruritus—Methylprednisolone—psoriatic arthritis	0.000896	0.00308	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000868	0.00298	CcSEcCtD
Fingolimod—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000867	0.00298	CcSEcCtD
Fingolimod—Fatigue—Prednisone—psoriatic arthritis	0.000865	0.00297	CcSEcCtD
Fingolimod—Headache—Prednisolone—psoriatic arthritis	0.000865	0.00297	CcSEcCtD
Fingolimod—Dizziness—Triamcinolone—psoriatic arthritis	0.000839	0.00288	CcSEcCtD
Fingolimod—Dizziness—Methylprednisolone—psoriatic arthritis	0.000838	0.00288	CcSEcCtD
Fingolimod—Infection—Methotrexate—psoriatic arthritis	0.000833	0.00286	CcSEcCtD
Fingolimod—Asthenia—Dexamethasone—psoriatic arthritis	0.000826	0.00284	CcSEcCtD
Fingolimod—Asthenia—Betamethasone—psoriatic arthritis	0.000826	0.00284	CcSEcCtD
Fingolimod—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000822	0.00282	CcSEcCtD
Fingolimod—Pruritus—Betamethasone—psoriatic arthritis	0.000815	0.0028	CcSEcCtD
Fingolimod—Pruritus—Dexamethasone—psoriatic arthritis	0.000815	0.0028	CcSEcCtD
Fingolimod—Skin disorder—Methotrexate—psoriatic arthritis	0.000814	0.0028	CcSEcCtD
Fingolimod—Headache—Triamcinolone—psoriatic arthritis	0.000795	0.00273	CcSEcCtD
Fingolimod—Headache—Methylprednisolone—psoriatic arthritis	0.000793	0.00272	CcSEcCtD
Fingolimod—Diarrhoea—Betamethasone—psoriatic arthritis	0.000788	0.00271	CcSEcCtD
Fingolimod—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000788	0.00271	CcSEcCtD
Fingolimod—Hypotension—Methotrexate—psoriatic arthritis	0.000783	0.00269	CcSEcCtD
Fingolimod—Dizziness—Dexamethasone—psoriatic arthritis	0.000762	0.00262	CcSEcCtD
Fingolimod—Dizziness—Betamethasone—psoriatic arthritis	0.000762	0.00262	CcSEcCtD
Fingolimod—Paraesthesia—Methotrexate—psoriatic arthritis	0.000753	0.00258	CcSEcCtD
Fingolimod—Dyspnoea—Methotrexate—psoriatic arthritis	0.000747	0.00257	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000724	0.00248	CcSEcCtD
Fingolimod—Fatigue—Methotrexate—psoriatic arthritis	0.000723	0.00248	CcSEcCtD
Fingolimod—Headache—Dexamethasone—psoriatic arthritis	0.000722	0.00248	CcSEcCtD
Fingolimod—Headache—Betamethasone—psoriatic arthritis	0.000722	0.00248	CcSEcCtD
Fingolimod—Asthenia—Prednisone—psoriatic arthritis	0.00072	0.00247	CcSEcCtD
Fingolimod—Pruritus—Prednisone—psoriatic arthritis	0.00071	0.00244	CcSEcCtD
Fingolimod—Diarrhoea—Prednisone—psoriatic arthritis	0.000686	0.00236	CcSEcCtD
Fingolimod—Dizziness—Prednisone—psoriatic arthritis	0.000663	0.00228	CcSEcCtD
Fingolimod—Headache—Prednisone—psoriatic arthritis	0.000628	0.00216	CcSEcCtD
Fingolimod—Asthenia—Methotrexate—psoriatic arthritis	0.000601	0.00207	CcSEcCtD
Fingolimod—Pruritus—Methotrexate—psoriatic arthritis	0.000593	0.00204	CcSEcCtD
Fingolimod—Diarrhoea—Methotrexate—psoriatic arthritis	0.000574	0.00197	CcSEcCtD
Fingolimod—Dizziness—Methotrexate—psoriatic arthritis	0.000554	0.0019	CcSEcCtD
Fingolimod—Headache—Methotrexate—psoriatic arthritis	0.000525	0.0018	CcSEcCtD
